On February 24, 2023, the Drug Enforcement Agency announced proposed rules for prescribing controlled substances via telemedicine after the COVID-19 Public Health Emergency expires. The proposed rules are open for public comment for only thirty days, after which DEA will issue final regulations.| Foley & Lardner LLP
The COVID-19 pandemic sparked dramatic shifts in the healthcare industry, including the way providers can prescribe, receive and view prescriptions.| CoverMyMeds Insights